- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), the premier specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, announced that two senior members of its team have been invited to present at the Emerging Technology Investment Forum Jan. 23-24 in San Jose. Kathy Conte, managing director of life sciences, and Sam Bhaumik, senior managing director and group head of technology, will be presenting at the event.
The event will provide a forum for entrepreneurs and early-stage small businesses in the life sciences and technology industries interested in securing venture capital funding to learn about best practice strategies and approaches from venture capital and angel investment firms like Hercules.
Conte will be participating in a panel discussion on Jan. 24 from 9-10:30 a.m. PT focused on opportunities and challenges for start-up companies in the life sciences industry. Bhaumik will participate in a similar panel discussion from 1:30-3 p.m. PT on Jan. 24 focusing on the technology industry. Both Bhaumik and Conte will highlight the competitive advantages of venture debt as an alternative source of growth capital for start-up companies in these sectors.
The forum - sponsored by the International Association of Nanotechnology - anticipates 45-50 presenting companies in major emerging technology fields, including clean tech, nanotech, biotech, aerospace, medical device and instruments as well as pharmaceuticals.
About Hercules Technology Growth Capital, Inc.
Hercules Technology Growth Capital, Inc. is a NASDAQ traded specialty finance company providing debt and equity growth capital to technology and life science companies at all stages of development. Founded in December 2003, the company primarily finances privately held companies backed by leading venture capital and private equity firms. Hercules invests in a broad range of ventures active in technology and life science industries and offers a full suite of growth capital products up and down the capital structure. The company is headquartered in Palo Alto, Calif. and has additional offices in the Boston, Boulder, San Diego and Chicago areas. Providing capital to publicly-traded or privately-held companies backed by leading venture capital and private equity firms involves a high degree of credit risk and may result in potential losses of capital. For more information, please visit www.HTGC.com.
Companies interested in learning more about financing opportunities should contact or call 650.289.3060.
The statements contained in this release that are not purely historical are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties and other factors we identify from time to time in our filings with the Securities and Exchange Commission. Although we believe that the assumptions on which these forward-looking statements are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Hercules assumes no obligation to update the forward-looking statements for subsequent events.
For more information, please click here
Hercules Technology Growth Capital, Inc.
Main, 650.289.3060 HT-HN
Sally Borg, 650.289.3066
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Chivalrous Knight Does Pro Bono June 27th, 2015
Exagan Raises €5.7 Million to Produce High-efficiency GaN-on-Silicon Power-switching Devices on 200mm Wafers: Leti-and-Soitec Spinout Focused on Becoming Leading European Source Of GaN Devices for Solar, Automotive, Telecoms and Infrastructure June 25th, 2015
Producing spin-entangled electrons July 2nd, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015